Menu
Not yet recruiting NCT07005310

Ultra-Long Peripheral Catheter Versus Accelerated Seldinger Technique Long Peripheral Catheter in Difficult IV Access Patients

No phase Interventional Difficult Intravenous Access Adults

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Powerglide pro™, Introcan safety deep access.
Who it may be relevant to
Registry conditions: Difficult Intravenous Access, Adults. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Ultra Long Peripheral Catheter Versus Accelerated Seldinger Technique Long Peripheral Catheter in Difficult Intravenous Access Patients: a Pragmatic Randomised Controlled Trial

Overview

The aim of this study is to perform a comparative analysis of clinical outcomes associated with the use of an ultra-long peripheral catheter using (catheter-over-the-needle technique) versus an AST-long peripheral catheter in adult patients with difficult intravenous access (DIVA) in a real-world clinical setting. Specifically, the study will assess potential benefits, including longer mean catheter dwell time and improved catheter usability, as well as potential harms, such as increased incidence of catheter-related thrombosis, infections, phlebitis, infiltration, and unplanned catheter removal.

Interventions

  • Device Powerglide pro™
    A long peripheral catheter will be placed under ultrasound guidance. This catheter will be placed by using the Accelerated seldinger technique.
  • Device Introcan safety deep access
    The catheter will be placed using ultrasound guidance and by using the 'catheter-over-the needle' approach.

Primary outcome measures

  • Dwell time [Time frame: Until study completion, an average of 14 days.]
Secondary outcome measures (5)
  • Number of Participants with Catheter related thrombosis [Time frame: Until study completion, an average of 14 days.]
  • Number of Participants with Midline catheter related infections [Time frame: Until study completion, an average of 14 days.]
  • Number of Participants with Phlebitis [Time frame: Until study completion, an average of 14 days.]
  • Number of Participants with Loss of catheter usability [Time frame: Until study completion, an average of 14 days.]
  • Number of Participants with Unplanned removal [Time frame: Until study completion, an average of 14 days.]

Eligibility criteria

Inclusion criteria

  • Adult inpatients with DIVA, requiring placement of a long peripheral catheter, will be included in the study.
  • A digital request form for venous access must be completed by the treating physician at the ward.
  • Patients must be proficient in either Dutch or French
  • Patients must have decision-making capacity or be represented by a legal representative.

Exclusion criteria

  • Expected therapy duration of less than 24 hours
  • pregnancy
  • Need for central venous access
  • Inability to locate a deep peripheral vein in the upper extremity prior enrollment in the study
  • Veins located deeper than 1.6cm prior enrollment in the study
  • withdrawal of consent, or presentation at a time when study personnel are unavailable.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Diagnostic

Study locations

Belgium · 1 center
  • Universitair ziekenhuis Brussel — Brussels

Publications

  • Pieteraerens W, Vanhonacker D, Beeckman K, Torsy T. Ultra long peripheral catheter versus accelerated Seldinger technique long peripheral catheter in difficult intravenous access patients (ULAST): a pragmatic randomised controlled trial protocol. BMJ Open. 2026 Feb 6;16(2):e106079. doi: 10.1136/bmjopen-2025-106079. PMID 41651529

Identifiers

NCT: NCT07005310 · ONZ-2024-0303

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗